Skip to main content

Table 2 Clinical characteristics of patients

From: Prediction of lymph node status in patients with early-stage cervical cancer based on radiomic features of magnetic resonance imaging (MRI) images

Variables

Total (n = 180)

Non-LNM (n = 131)

LNM (n = 49)

P

Age, years, Mean ± SD

53.07 ± 9.79

52.87 ± 10.20

53.61 ± 8.69

0.652

Marital status, n (%)

   

1.000

 Unmarried

2 (1.11)

2 (1.53)

0 (0.00)

 

 Married

178 (98.89)

129 (98.47)

49 (100.00)

 

Reproductive history, n (%)

   

0.576

 No

4 (2.22)

4 (3.05)

0 (0.00)

 

 Yes

176 (97.78)

127 (96.95)

49 (100.00)

 

Weight, kg, Mean ± SD

62.13 ± 9.88

61.61 ± 10.11

63.54 ± 9.21

0.244

Menopausal status, n (%)

   

0.630

 Non-menopausal

67 (37.22)

50 (38.17)

17 (34.69)

 

 Peri-menopause

16 (8.89)

10 (7.63)

6 (12.24)

 

 Post-menopausal

97 (53.89)

71 (54.20)

26 (53.06)

 

FIGO stage, n (%)

   

0.018

 IA2

11 (6.11)

4 (3.05)

7 (14.29)

 

 IB1

2 (1.11)

2 (1.53)

0 (0.00)

 

 IB2

45 (25.00)

38 (29.01)

7 (14.29)

 

 IB3

53 (29.44)

39 (29.77)

14 (28.57)

 

 IIA1

18 (10.00)

10 (7.63)

8 (16.33)

 

 IIA2

51 (28.33)

38 (29.01)

13 (26.53)

 

White blood cells, 10^9/L, M (Q1, Q3)

6.85 (5.64,8.87)

6.92 (5.65,8.72)

6.47 (5.62,9.24)

0.684

Eosinophil count, 10^9/L, M (Q1, Q3)

0.10 (0.05,0.20)

0.11 (0.05,0.21)

0.08 (0.06,0.13)

0.251

Basophil count, 10^9/L, M (Q1, Q3)

0.01 (0.00,0.02)

0.01 (0.00,0.02)

0.01 (0.00,0.02)

0.627

Monocyte count, 10^9/L, M (Q1, Q3)

0.43 (0.34,0.54)

0.43 (0.34,0.54)

0.41 (0.33,0.51)

0.483

Red blood cells, 10^12/L, Mean ± SD

4.14 ± 0.58

4.16 ± 0.57

4.10 ± 0.61

0.574

Hemoglobin, g/L, Mean ± SD

120.68 ± 18.14

121.92 ± 17.45

117.35 ± 19.68

0.132

Hematocrit, %, Mean ± SD

36.23 ± 4.92

36.53 ± 4.71

35.44 ± 5.42

0.187

Mean corpuscular volume, fL, Mean ± SD

87.48 ± 6.47

87.86 ± 6.52

86.45 ± 6.29

0.195

Mean corpuscular hemoglobin, pg, Mean ± SD

29.16 ± 2.79

29.35 ± 2.76

28.66 ± 2.82

0.138

Mean erythrocyte hemoglobin concentration, g/L, Mean ± SD

332.57 ± 13.59

333.53 ± 13.10

330.00 ± 14.64

0.122

Red blood cell distribution width- coefficient of variation, %, Mean ± SD

13.57 ± 1.91

13.41 ± 1.69

14.01 ± 2.37

0.110

Red blood cell distribution width-standard deviation, %, Mean ± SD

42.75 ± 3.66

42.53 ± 3.37

43.34 ± 4.33

0.240

Mean platelet volume, fL, Mean ± SD

10.76 ± 1.13

10.80 ± 1.11

10.66 ± 1.18

0.479

Thrombocytocrit, %, Mean ± SD

0.28 ± 0.79

0.28 ± 0.81

0.29 ± 0.74

0.455

Platelet distribution width, %, Mean ± SD

13.09 ± 2.54

13.15 ± 2.69

12.92 ± 2.11

0.587

Platelet large cell ratio, %, Mean ± SD

31.13 ± 9.27

31.21 ± 9.58

30.92 ± 8.50

0.853

Squamous cell carcinoma antigen, ng/mL, M (Q1, Q3)

1.63 (0.84,4.55)

1.50 (0.80,3.80)

3.60 (1.20,10.76)

< 0.001

  1. Note: LNM, lymph node metastasis; FIGO, the International Federation of Gynecology and Obstetrics